Llwytho...
Antiviral Effect of Budesonide against SARS-CoV-2
Treatment options for COVID-19, a disease caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection, are currently severely limited. Therefore, antiviral drugs that efficiently reduce SARS-CoV-2 replication or alleviate COVID-19 symptoms are urgently needed. Inhaled glucocorti...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Viruses |
|---|---|
| Prif Awduron: | , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
MDPI
2021
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8310374/ https://ncbi.nlm.nih.gov/pubmed/34372616 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/v13071411 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|